Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/4/2025

Management of Severe Postpartum Anemia After Transfusion

Immediate Post-Transfusion Monitoring and Expected Hemoglobin Response

  • The American College of Obstetricians and Gynecologists recommends monitoring vital signs every 1-2 hours for the first 24 hours after transfusion, watching specifically for signs of transfusion reactions or volume overload, in patients with severe postpartum anemia 1
  • Calculate the Shock Index (heart rate ÷ systolic blood pressure): A value >1 indicates hemodynamic instability requiring immediate intervention, in patients who have received blood transfusions for severe anemia 1
  • Monitor urine output closely, as oliguria may indicate ongoing hypovolemia or development of complications, in patients with severe postpartum anemia 1
  • Each unit of packed red blood cells should increase hemoglobin by approximately 1 g/dL, so expect Hb to rise to approximately 6.6-6.8 g/dL after 2 units, in patients with severe postpartum anemia 2
  • Recheck hemoglobin 4-6 hours after transfusion completion to confirm adequate response and determine if additional transfusion is needed, in patients with severe postpartum anemia 1
  • If hemoglobin remains <7.0 g/dL after transfusion, consider additional units, transfusing one unit at a time with reassessment between units, in patients with severe postpartum anemia 1

Diagnostic Workup for Profound Anemia

  • Perform pelvic ultrasound with color Doppler to exclude retained products of conception, hematoma formation, or vascular abnormalities, in patients with severe postpartum anemia 2
  • Measure cumulative blood loss using volumetric techniques, as visual estimation consistently underestimates actual loss, in patients with severe postpartum anemia 1, 3
  • Order peripheral blood smear immediately to look for schistocytes indicating microangiopathic hemolysis, in patients with severe postpartum anemia 2
  • Check haptoglobin and LDH if hemolysis is occurring, in patients with severe postpartum anemia 2
  • Perform direct Coombs test to exclude autoimmune hemolysis, in patients with severe postpartum anemia 2
  • Assess reticulocyte count to evaluate bone marrow response, in patients with severe postpartum anemia 2

Coagulopathy and Thrombotic Microangiopathy

  • Check fibrinogen level: Normal postpartum is 4-6 g/L; <2 g/L suggests consumptive coagulopathy, in patients with severe postpartum anemia 2, 4
  • Obtain PT/APTT and platelet count to assess for delayed coagulopathy, in patients with severe postpartum anemia 3, 4
  • If thrombocytopenia is worsening beyond day 5 postpartum with persistent hemolysis, immediately measure ADAMTS13 activity level and consider atypical hemolytic uremic syndrome (aHUS), in patients with severe postpartum anemia 2
  • aHUS has high mortality without complement blockade but excellent outcomes with eculizumab, in patients with severe postpartum anemia 2

Volume Overload Risk and Transfusion

  • Monitor carefully for signs of transfusion-associated circulatory overload (TACO), particularly if the patient has preeclampsia or cardiac disease, in patients with severe postpartum anemia 1, 5
  • Transfuse additional units if Hb remains <7.0 g/dL regardless of symptoms, in patients with severe postpartum anemia 1
  • Consider transfusion if Hb 7.0-8.0 g/dL with cardiac disease, ongoing bleeding, or hemodynamic instability, in patients with severe postpartum anemia 1
  • Transfuse one unit at a time and recheck hemoglobin before each subsequent unit unless there is active hemorrhage, in patients with severe postpartum anemia 1